Cosentyx

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

Novartis trumpets long-term data for Cosentyx in psoriasis

https://pharmaphorum.com/news/novartis-trumpets-long-term-data-cosentyx-psoriasis/

Imbruvica, Opdivo and Praluent gain approvals for Scotland’s NHS

https://pharmaphorum.com/news/imbruvica-opdivo-praluent-gain-approvals-scotlands-nhs/

Close in 10 seconds

Pharmaphorum.com

Search